Skip to main navigation

About
Indications
Science
- Science
- DKK1
- DKN-01
Patients
Careers
Investors

News
Releases

image description

News Releases

Year

Jan 17, 2023

Leap Therapeutics Acquires Flame Biosciences

Jan 11, 2023

Leap Therapeutics to Present at B. Riley Securities' 3rd Annual Oncology Conference

Print Page
Email Alerts
Contact Us

image description

image description

47 Thorndike Street, Suite B1-1 Cambridge, MA 02141 USA

+1 617 714 0360

Business inquiries
bd@leaptx.com

Investor inquiries
ir@leaptx.com

About

Contact Us
Partnership

Careers

Indications

Gastric Cancer
Endometrial Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Colorectal Cancer

Science

DKK1
DKN-01

Patients

Investors

Stock Information
News Releases
Presentations & Events
Financial Information
Corporate Governance
Information Request

© 2022 Leap Therapeutics, Inc.
All Rights Reserved.

Terms of Use
Privacy Policy